Mentioned 9× · first seen 08-jul-2026 · last seen 09-jul-2026

Prescription Drug Copay Accumulator & Assistance Rules

Current understanding

To be populated as evidence accumulates.

Evidence log

2026-06-10 — Insurance: health insurers; coverage for prescription inhalers; require. Amends 1956 PA 218 (MCL 500.100 - 500.8302) by adding sec. 3406xx.: Related drug-specific insurance coverage mandate in the same act: SB1034 would add sec. 3406xx to 1956 PA 218 to require health insurers to cover prescription inhalers, paralleling other sec. 3406-series mandates (epinephrine, insulin) that expand prescription drug access. (novelty: 2)
2026-06-10 — Insurance: health insurers; cost-sharing for insulin coverage; eliminate. Amends 1956 PA 218 (MCL 500.100 - 500.8302) by adding sec. 3406qq.: Related but more aggressive insulin cost-sharing measure using the same new section number: SB1033 would add sec. 3406qq to 1956 PA 218 to eliminate cost-sharing entirely for insulin coverage, going beyond HB6101’s proposed co-pay cap and paralleling sec. 3406nn’s broader prescription drug cost-sharing protections. (novelty: 2)
2026-06-10 — Insurance: health insurers; coverage for epinephrine; require. Amends 1956 PA 218 (MCL 500.100 - 500.8302) by adding sec. 3406ww.: Related prescription-drug coverage mandate in the same act: SB1032 would add sec. 3406ww to 1956 PA 218 to require health insurers to cover epinephrine, paralleling other sec. 3406-series insurer mandates targeting specific drug affordability and access. (novelty: 2)
2026-06-18 — Insurance: health insurers; coverage for emergency refill of prescription medication for up to a 30-day supply; repeal. Amends sec. 3406o of 1956 PA 218 (MCL 500.3406o) & repeals sec. 3406w of 1956 PA 218 (MCL 500.3406w).: Related prescription-drug insurance amendment in the same act moving in the opposite direction: SB0978 would repeal sec. 3406w (and amend sec. 3406o) of 1956 PA 218 to eliminate the mandate that insurers cover emergency prescription refills of up to a 30-day supply, contrasting with sec. 3406nn’s expansion of prescription-drug cost-sharing protections. (novelty: 2)
2026-06-17 — Insurance: health insurers; limit amount on co-pay for prescription insulin; provide for. Amends 1956 PA 218 (MCL 500.100 - 500.8302) by adding sec. 3406qq.: Related but distinct prescription-drug cost-sharing measure in the same act: HB6101 would add sec. 3406qq to 1956 PA 218 to cap insurer co-pays specifically for prescription insulin, paralleling the sec. 3406nn copay-accumulator approach for prescription drug cost-sharing more generally. (novelty: 2)
2026-06-25 — Consumer protection: unfair trade practices; insulin drug pricing report; require by the department of attorney general. Amends 1976 PA 331 (MCL 445.901 - 445.922) by adding sec. 9b.: Related drug-affordability effort via a different statutory vehicle: HB6132 would amend the Consumer Protection Act (1976 PA 331) by adding sec. 9b to require the Department of Attorney General to produce an insulin drug pricing report, complementing insurance-side copay reforms. (novelty: 2)
2026-07-03 — Insurance: health insurers; methods of payments and reimbursements for dental benefits; provide for. Amends 1956 PA 218 (MCL 500.100 - 500.8302) by adding sec. 3406ss.: Related insurer-payment-methods amendment: SB0105 would add sec. 3406ss to the same act (1956 PA 218) governing insurer payments/reimbursements for dental benefits, paralleling the sec. 3406nn approach for prescription drug copays. (novelty: 2)
2026-07-03 — Insurance: health benefits; application of amount paid by the insured or other certain parties when calculating the insured’s co-pay for a prescription drug; require under certain conditions. Amends 1956 PA 218 (MCL 500.100 - 500.8302) by adding sec. 3406nn.: HB6212 introduced in the 103rd Michigan Legislature would add sec. 3406nn to 1956 PA 218, requiring insurers to count amounts paid by the insured or certain third parties (e.g., manufacturer copay assistance) toward the insured’s prescription drug co-pay calculation under specified conditions. (novelty: 2)